BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20531147)

  • 1. Diagnostic and therapeutic challenges.
    Gupta OP; Garg SJ; Negrey JN; Jahnle R; Pasion R; Ip MS; Hwang FS; Kaines A; Jain AK; Schwartz SD
    Retina; 2010 Jun; 30(6):975-80. PubMed ID: 20531147
    [No Abstract]   [Full Text] [Related]  

  • 2. Spectral domain optical coherence tomography and angiographic findings in central serous chorioretinopathy complicated by bilateral nonrhegmatogenous retinal detachment associated with systemic corticosteroids.
    Arantes TE; Garcia CR; Rossi MR; Muccioli C
    Ocul Immunol Inflamm; 2009; 17(5):316-8. PubMed ID: 19831561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and therapeutic challenges.
    Ascaso FJ; Rojo M; Minguez E; Cohen SM; Yang SS
    Retina; 2011 Mar; 31(3):616-22. PubMed ID: 21336073
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic and therapeutic challenges.
    De Salvo G; Keane PA; Tufail A; Sarraf D
    Retina; 2015 Feb; 35(2):374-7. PubMed ID: 24732696
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical factors related to visual outcome in central serous chorioretinopathy.
    Aggio FB; Roisman L; Melo GB; Lavinsky D; Cardillo JA; Farah ME
    Retina; 2010; 30(7):1128-34. PubMed ID: 20616688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central serous chorioretinopathy in patients receiving exogenous testosterone therapy.
    Nudleman E; Witmer MT; Kiss S; Williams GA; Wolfe JD
    Retina; 2014 Oct; 34(10):2128-32. PubMed ID: 24946102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central serous chorioretinopathy in young adults.
    Pryds A; Larsen M; Barbazetto I; Yannuzzi L
    Acta Ophthalmol; 2012 Aug; 90(5):e404-5. PubMed ID: 23043628
    [No Abstract]   [Full Text] [Related]  

  • 8. Morphologic findings in acute central serous chorioretinopathy using spectral domain-optical coherence tomography with simultaneous angiography.
    Shinojima A; Hirose T; Mori R; Kawamura A; Yuzawa M
    Retina; 2010 Feb; 30(2):193-202. PubMed ID: 20142712
    [No Abstract]   [Full Text] [Related]  

  • 9. Reading performance with different contrast characters in patients with central serous chorioretinopathy.
    Fujita K; Matsumoto CS; Mizutani Y; Imamura Y; Tanaka E; Satofuka S; Shinoda K; Mizota A; Oda K; Yuzawa M
    Acta Ophthalmol; 2012 Nov; 90(7):e575-7. PubMed ID: 22405126
    [No Abstract]   [Full Text] [Related]  

  • 10. Photopigments in central serous chorioretinopathy.
    Ojima A; Iida T; Sekiryu T; Maruko I; Sugano Y
    Am J Ophthalmol; 2011 Jun; 151(6):940-952.e1. PubMed ID: 21457927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal imaging findings in a case of severe Central Serous Chorioretinopathy in an uncomplicated pregnancy.
    Maggio E; Polito A; Freno MC; Pertile G
    BMC Ophthalmol; 2015 Dec; 15():183. PubMed ID: 26695180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography.
    Tsujikawa A; Ojima Y; Yamashiro K; Ooto S; Tamura H; Nakagawa S; Yoshimura N
    Retina; 2010 May; 30(5):801-9. PubMed ID: 20094008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Shin JY; Woo SJ; Yu HG; Park KH
    Retina; 2011 Jan; 31(1):119-26. PubMed ID: 20890242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and therapeutic challenges.
    Wong IY; Lam JK; Cebulla CM
    Retina; 2013 May; 33(5):1076-80. PubMed ID: 23296050
    [No Abstract]   [Full Text] [Related]  

  • 15. Value of three-dimensional optical coherence tomography and fundus photochromy in correlating the fluorescein leaking sites of acute central serous chorioretinopathy.
    Wang GH; Zhang J; Zhang D; Lv FL; Wang LX
    Med Princ Pract; 2011; 20(3):283-6. PubMed ID: 21455001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central serous chorioretinopathy as a presenting symptom of endogenous Cushing syndrome: a case report.
    Iannetti L; Spinucci G; Pesci FR; Vicinanza R; Stigliano A; Pivetti-Pezzi P
    Eur J Ophthalmol; 2011; 21(5):661-4. PubMed ID: 21404219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
    Imamura Y; Fujiwara T; Spaide RF
    Ophthalmology; 2011 Apr; 118(4):700-5. PubMed ID: 21055816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective retina therapy for acute central serous chorioretinopathy.
    Klatt C; Saeger M; Oppermann T; Pörksen E; Treumer F; Hillenkamp J; Fritzer E; Brinkmann R; Birngruber R; Roider J
    Br J Ophthalmol; 2011 Jan; 95(1):83-8. PubMed ID: 20554506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral central serous chorioretinopathy associated with estrogen modulator diindolylmethane.
    Bussel II; Lally DR; Waheed NK
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):589-91. PubMed ID: 25423641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased fundus autofluorescence related to outer retinal disruption.
    Freund KB; Mrejen S; Jung J; Yannuzzi LA; Boon CJ
    JAMA Ophthalmol; 2013 Dec; 131(12):1645-9. PubMed ID: 24136134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.